期刊
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
卷 96, 期 1, 页码 52-58出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pbb.2010.04.006
关键词
H2S; LPS; Alzheimer's disease; Cognitive impairment; TNF-alpha; NF-kappa B
资金
- National Natural Science foundation of China [30888002]
- National Basic Research Program of China (973 Program) [2010CB912600]
The present study investigated the effect of sodium hydrosulfide (NaHS), a H2S donor, on cognitive impairment and neuroinflammatory changes induced by bilateral intracerebroventricular injections of LPS at a dose of 10 mu g/rat. Rats received 5 mg/kg NaHS or volume-matched vehicle administration by intraperitoneal injection 3 days before LPS injection then for 9 days once daily. Morris water maze was used to detect the cognitive function. Compared to the sham-treated rats, LPS injection significantly prolonged the mean escape latency in the navigation test (P<0.05) and shortened the adjusted escape latency by approximately 30% (P<0.05). Meanwhile, LPS injection decreased H2S level but increased pro-inflammatory mediators (i.e., TNF-alpha, TNFR1, degradation of I kappa B-alpha and thereafter activation of NF-kappa B) in hippocampus. However, these effects of LPS were significantly ameliorated with NaHS treatment (P<0.05 vs vehicle-treated group). The present data suggest that H2S attenuates LPS-induced cognitive impairment through reducing the overproduction of pro-inflammatory mediators via inhibition of NF-kappa B pathways in rats. This study sets the stage for exploring a novel H2S releasing agent for preventing or retarding the development or progression of neurological disorders such as Alzheimer's disease. (C) 2010 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据